|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | TA Associates, a leading buyout and private equity firm. |
|---|---|
| Transferring Party | Alere Medical Incorporated, a leading disease management company focused on asthma, chronic obstructive pulmonary disorder, coronary artery disease, diabetes and heart failure. |
| Sector | Medical Services |
| Date | April 3, 2007 |
| Analysis Disease management (DM) considered an important tool to drive down costs, especially by focusing on the chronic diseases that account for a disproportionately high share of healthcare costs. DM industry expects an 18% compounded annual growth rate to $1.9 billion of revenue by 2008, according to a Boston Consulting Group report. Deal value --$175m. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |